Infectious Disease & Infection Control Nursing GCC

Comprehensive guide for DHA · MOH · SCFHS · QCHP · HAAD licensing examinations | Updated April 2026

Infection Control Fundamentals

Standard Precautions

Apply to ALL patients regardless of diagnosis

  • Hand hygiene — WHO 5 moments (see accordion below)
  • PPE — gloves, gown, mask, eye protection based on exposure risk
  • Respiratory hygiene — cough etiquette, surgical mask on coughing patient
  • Safe injection practices — single-use needles, never recap, aseptic technique
  • Sharps safety — safety-engineered devices, sharps containers at point of use
  • Safe handling of linen & waste — clinical waste = yellow bags
  • Environmental cleaning — regular decontamination of patient-care equipment

Hand Hygiene Products

SituationProduct
Most routine careABHR gel
C. difficile sporesSoap + water
NorovirusSoap + water
Visibly soiled handsSoap + water
After restroomSoap + water
Alcohol gel is INEFFECTIVE against C. difficile and Norovirus spores — soap and water is mandatory.

Transmission-Based Precautions

Contact Precautions

Gloves + gown for all contact

Organisms:
  • MRSA (Meticillin-resistant S. aureus)
  • VRE (Vancomycin-resistant Enterococcus)
  • C. difficile — soap + water
  • Norovirus — soap + water
  • Scabies / extensive wound infection
  • CPE (Carbapenem-producing Enterobacterales)
Single room preferred

Droplet Precautions

Surgical mask within 1 m

Organisms:
  • Influenza A & B
  • Meningococcal meningitis
  • Pertussis (whooping cough)
  • Rubella / Mumps
  • RSV (Respiratory Syncytial Virus)
  • Diphtheria (pharyngeal)
Single room preferred

Airborne Precautions

N95 respirator required

Organisms:
  • Tuberculosis (TB) — pulmonary/laryngeal
  • Measles (Rubeola)
  • Chickenpox / Varicella-Zoster
  • COVID-19 (aerosol-generating procedures)
  • MERS-CoV (see Tab 5)
  • Smallpox / Monkeypox (+ contact)
Negative pressure room required

PPE Donning & Doffing Sequence

DONNING (putting on)

1Perform hand hygiene
2Put on gown / apron (tie at neck first, then waist)
3Apply mask / N95 respirator (perform seal check)
4Apply eye protection / face shield
5Put on gloves LAST — pull over gown cuffs

DOFFING (removing) — contaminated outside!

1Remove gloves FIRST — peel off inside-out
2Perform hand hygiene
3Remove gown — roll away from body, do not shake
4Perform hand hygiene
5Remove eye protection (handle by headband)
6Remove mask / N95 (handle by ties/elastic, not front)
7Perform hand hygiene
Critical rule: Gloves = LAST ON, FIRST OFF. The gloves are the most contaminated item. Never touch your face during doffing.

WHO Hand Hygiene — 5 Moments & Audit Checklist

▶

The 5 Moments

1
Before touching a patient
Prevents transfer of germs from environment to patient
2
Before a clean/aseptic procedure
IV insertion, wound dressing, urinary catheter care
3
After body fluid exposure risk
Even if gloves were worn
4
After touching a patient
Prevents cross-contamination to other patients
5
After touching patient surroundings
Bed rails, call bell, IV pump — even without touching patient

Audit Checklist

Observation PointCompliantAction
Moment 1 observed☐ Yes ☐ NoFeedback if No
Moment 2 observed☐ Yes ☐ NoFeedback if No
Moment 3 observed☐ Yes ☐ NoFeedback if No
Moment 4 observed☐ Yes ☐ NoFeedback if No
Moment 5 observed☐ Yes ☐ NoFeedback if No
Duration ≥15–30 sec (gel) / 40–60 sec (soap)☐ Yes ☐ NoRe-educate
Correct technique (all surfaces)☐ Yes ☐ NoDemonstrate
No jewellery / bare below elbow☐ Yes ☐ NoPolicy reminder
Target hand hygiene compliance: ≥80% (WHO recommendation), ≥90% (GCC best practice)

Needle-Stick Injury Management Algorithm

▶
Immediate Actions (within minutes): 1. Do NOT panic — do not suck the wound. 2. Wash wound immediately with soap and water for ≥5 minutes. 3. Allow wound to bleed freely — do not squeeze. 4. Apply antiseptic (chlorhexidine or povidone-iodine). 5. Report to supervisor IMMEDIATELY.

Blood-Borne Virus Transmission Risk

VirusRisk per Needle-Stick
HIV0.3%
Hepatitis C (HCV)1.8%
Hepatitis B (HBV) — unvaccinated6–30%
HBV — vaccinated (anti-HBs ≥10)<1%

Post-Exposure Protocol

  1. Immediate first aid (wash + bleed)
  2. Report to Occupational Health within 1–2 hours
  3. Source patient consent for HIV/HCV/HBV testing
  4. HIV PEP: must start within 72 hours (ideally <2 hrs)
  5. HBV immune globulin (HBIG) if unvaccinated within 24 hrs
  6. Follow-up bloods at 6 weeks, 3 months, 6 months
  7. Complete incident report documentation
PEP = Post-Exposure Prophylaxis. Never delay — every hour counts for HIV PEP efficacy.
Healthcare-Associated Infections (HAIs)

CLABSI Bundle

Central Line-Associated Blood Stream Infection

  1. Hand hygiene before insertion and dressing changes
  2. Maximal barrier precautions — sterile gown, gloves, mask, cap, large drape
  3. Chlorhexidine 2% skin antisepsis — scrub for ≥30 sec, dry completely
  4. Optimal catheter site — subclavian preferred; femoral highest risk
  5. Daily review of line necessity — remove as soon as no longer needed
  6. Sterile dressing changes every 7 days (or if soiled/loose)
  7. Needleless connectors — decontaminate before access (15 sec scrub)

CAUTI Bundle

Catheter-Associated Urinary Tract Infection

  1. Insert only when indicated — not for nursing convenience
  2. Aseptic insertion technique — smallest appropriate catheter
  3. Maintain closed drainage system — never disconnect
  4. Secure catheter — prevent traction and movement
  5. Drainage bag below bladder — never on floor, never elevated above bladder
  6. Daily review of necessity — remove promptly when not indicated
  7. Peri-urethral care with soap and water during daily bathing

VAP Bundle

Ventilator-Associated Pneumonia

  1. Head of bed elevation 30–45° unless contraindicated
  2. Oral decontamination with chlorhexidine 0.12–0.2% every 4–6 hours
  3. Subglottic secretion suctioning before cuff deflation/repositioning
  4. Sedation vacation daily — assess readiness to wean
  5. Spontaneous Breathing Trial (SBT) daily when sedation off
  6. Avoid routine circuit changes — change only when visibly soiled
  7. Maintain cuff pressure 20–30 cmH₂O

SSI Prevention

Surgical Site Infection

  • Pre-op MRSA decolonisation — nasal mupirocin + CHG wash ×5 days
  • Hair removal: clippers only — never shave with razors (micro-abrasions)
  • Skin prep: chlorhexidine-alcohol (superior to povidone-iodine)
  • Antibiotic prophylaxis: within 60 min of incision (120 min for vancomycin)
  • Normothermia: maintain temperature ≥36°C intra- and post-op
  • Glucose control: blood glucose <10 mmol/L peri-operatively
  • Wound dressing: maintain sterile technique for first 48 hours

MRSA Screening & Decolonisation

Screening Sites

  • Nasal swab — anterior nares (bilateral) — primary site
  • Groin / axilla swabs — standard bundle
  • Perineum, wound sites if present
  • Throat swab if respiratory symptoms

Who to Screen (GCC)?

  • All ICU admissions
  • Previous MRSA history
  • Transfers from other hospitals
  • Pre-surgical patients (high-risk procedures)

Decolonisation Protocol (5 Days)

1Mupirocin 2% nasal ointment — apply to anterior nares 3×/day for 5 days
2Chlorhexidine 4% body wash — full body wash daily for 5 days (avoid eyes/ears)
3Chlorhexidine 0.2% mouthwash if oropharyngeal MRSA
4Change bed linen and patient clothing daily during decolonisation

Environmental Decontamination

  • Hydrogen peroxide vapour (HPV) — terminal room decontamination
  • UV-C light — supplemental disinfection after manual cleaning
  • Both methods proven superior to manual cleaning alone
Antimicrobial Stewardship (AMS)

AMR Global Crisis — WHO Priority Pathogens

Antimicrobial resistance kills ~700,000 people/year globally. Projected 10 million deaths/year by 2050 without action.

ESKAPE Organisms (Critical Priority)

E Enterococcus faecium (VRE)
S Staphylococcus aureus (MRSA)
K Klebsiella pneumoniae (KPC/NDM)
A Acinetobacter baumannii (CRAB)
P Pseudomonas aeruginosa (CRPA)
E Enterobacterales (ESBL/CPE)

Blood Cultures — Critical Rules

  • Always take BEFORE antibiotics — 1 hour delay reduces sensitivity by 40%
  • 2 sets from 2 different sites (e.g., right antecubital + left antecubital)
  • Each set = 1 aerobic + 1 anaerobic bottle
  • Volume: 8–10 mL per bottle (adult)
  • Skin prep: chlorhexidine-alcohol — allow to dry fully
  • Bottle tops: decontaminate with alcohol swab before inoculation
  • Contamination benchmark: <3% (coagulase-negative staph typical contaminant)
  • Interpret with clinical context — 1 positive CoNS often contaminant

Culture-Directed De-escalation

  • Review culture results at 48–72 hours — narrow spectrum based on sensitivities
  • Broad → narrow (e.g., meropenem → amoxicillin if sensitive)
  • IV to Oral Switch (OPAT criteria): afebrile >24 hrs, tolerating oral, decreasing WBC, no IV-only indication, functioning GI tract
  • OPAT = Outpatient Parenteral Antibiotic Therapy

Penicillin Allergy De-labelling

Key fact: 90% of patients labelled "penicillin allergic" can safely tolerate penicillin or cephalosporins when formally assessed. Allergy de-labelling improves outcomes and reduces resistant organism selection.
  • True IgE-mediated allergy: rare (<1% of labelled patients)
  • Cross-reactivity penicillin/cephalosporin: <2% (not 10% as historically taught)
  • Allergy assessment: detailed history → skin prick test → oral challenge

Nursing Role in AMS — DART Framework

D
De-escalate
Prompt prescribers to narrow therapy when cultures available
A
Allergy review
Question vague allergy labels; facilitate formal assessment
R
Route change
IV → oral switch when patient meets criteria; reduces line complications
T
Treatment duration
Remind prescribers to set stop/review dates; shorter courses often equal

Common Antibiotic Classes

ClassExamplesKey Coverage
PenicillinsAmoxicillin, Pip-tazoGram+ & some Gram–
CephalosporinsCefazolin, CeftriaxoneBroad Gram– coverage
CarbapenemsMeropenem, ErtapenemBroadest (ESBL cover)
GlycopeptidesVancomycin, TeicoplaninMRSA, Gram+ only
FluoroquinolonesCiprofloxacin, LevofloxacinGram– & atypicals
MacrolidesAzithromycin, ClarithromycinAtypicals, Gram+
MetronidazoleFlagylAnaerobes, C.diff

GCC AMR Surveillance Networks

Notifiable Diseases & Outbreak Management

GCC Notifiable Diseases

Saudi MOH Notifiable

  • MERS-CoV
  • Meningococcal meningitis
  • Tuberculosis (all forms)
  • Typhoid fever
  • Cholera
  • Viral haemorrhagic fevers
  • Hepatitis A, B, C, E
  • Brucellosis
  • Measles / Rubella
  • COVID-19
  • Dengue fever
  • Rabies

DHA (Dubai) Notifiable

  • All above plus:
  • Legionellosis
  • Leptospirosis
  • Pertussis
  • Tetanus
  • Poliomyelitis
  • Anthrax
  • Leishmaniasis
  • Malaria
  • Food poisoning outbreaks

QCHP (Qatar) Notifiable

  • Immediate (within 24h): cholera, VHF, MERS, smallpox
  • Within 48h: meningitis, TB, typhoid, hepatitis
  • Weekly: influenza, food poisoning, gastroenteritis clusters
Report to relevant authority within 24–48 hours

Outbreak Definition & Investigation

  • Outbreak: more cases than expected in a defined time/place/population
  • Epidemic: widespread outbreak across larger geographical area
  • Cluster: geographic or temporal aggregation of cases

Investigation Steps

  1. Verify diagnosis — confirm cases with lab
  2. Establish case definition (confirmed/probable/suspected)
  3. Case counting — line listing (name, date, location, onset)
  4. Calculate attack rate = (cases ÷ exposed) × 100%
  5. Develop epidemic curve (x=time, y=cases)
  6. Form hypothesis about source/vehicle
  7. Implement control measures immediately
  8. Report to public health authority

Outbreak Control Nursing Actions

Cohort Nursing

  • Group patients with the same confirmed diagnosis together
  • Dedicated nursing staff for cohort (do not float between cohort & clean areas)
  • Separate cohort from susceptible/uninfected patients
  • Clear physical demarcation; dedicated equipment

Environmental Controls

  • Increase cleaning frequency (2–4×/day minimum during outbreak)
  • Use appropriate disinfectant (e.g., chlorine 1000 ppm for norovirus)
  • Terminal cleaning after patient discharge/transfer
  • Consider HPV/UV-C for rooms with confirmed resistant organisms

Food Safety — HACCP Principles

7 HACCP Principles

  1. Conduct hazard analysis
  2. Identify Critical Control Points (CCPs)
  3. Establish critical limits
  4. Establish monitoring procedures
  5. Establish corrective actions
  6. Establish verification procedures
  7. Establish record-keeping

Cold Chain Monitoring (GCC Climate)

  • Danger zone: 5°C – 63°C (bacteria multiply rapidly)
  • Refrigeration: ≤4°C (ideally 1–4°C)
  • Freezer: ≤-18°C
  • Hot holding: ≥63°C
  • Check fridge/freezer temperatures twice daily and document
  • GCC heat: particular risk — ensure no breaks in cold chain during transport
  • Food transported in insulated containers with ice packs
In GCC, ambient temperatures can reach 45–50°C. Cold chain failures are a significant public health risk, especially during Hajj/Umrah mass gatherings.
GCC-Specific Infections

MERS-CoV — Nursing Isolation Protocol (Full Detail)

▶

Epidemiology

  • Reservoir: Dromedary camels (zoonotic source)
  • Endemic region: Arabian Peninsula — Saudi Arabia accounts for >80% of global cases
  • Human-to-human: primarily in healthcare settings (nosocomial clusters)
  • Incubation: 2–14 days (median 5 days)
  • CFR: approximately 35% (highest of known coronaviruses)
  • Risk factors: exposure to camels, raw camel milk/urine, healthcare workers, elderly with comorbidities

Clinical Presentation

  • Fever, cough, shortness of breath (triad)
  • Pneumonia progressing to ARDS
  • GI symptoms (diarrhoea, vomiting) in 30%
  • Renal failure (distinguishes from other coronaviruses)

Nursing PPE Requirements

AIRBORNE + CONTACT precautions required
  • N95 respirator — must be fit-tested; PAPR if available
  • Full gown — fluid-repellent, long-sleeved
  • Gloves — double-gloving recommended
  • Eye protection — goggles + face shield
  • Negative pressure room — 6–12 ACH minimum

Isolation Nursing Protocol

  1. Place in negative pressure single room immediately on suspicion
  2. Limit staff access — designated MERS team only
  3. Minimise aerosol-generating procedures (intubation, bronchoscopy, BiPAP)
  4. If AGPs unavoidable — PAPR preferred over N95
  5. All PPE donned outside room; doffed in anteroom or designated area
  6. Notify IPC team and MOH within 24 hours of suspected case
  7. Contact tracing: all healthcare staff within 1 metre of patient
No specific antiviral treatment approved. Management is supportive: oxygen, fluids, ventilation, renal support. Experimental: remdesivir, interferons (research settings).

Brucellosis

GCC rural/farming communities
  • Cause: Brucella spp. (B. melitensis most common in GCC)
  • Transmission: raw milk, unpasteurised cheese (salty white cheese), direct animal contact (sheep, goats, camels), slaughterhouse workers
  • Symptoms: undulant (wave-like) fever, night sweats, arthralgia, hepatosplenomegaly, fatigue
  • Diagnosis: serology (Rose Bengal + SAT), blood cultures (prolonged incubation)
  • Treatment: Doxycycline + Rifampicin for 6 weeks (combination mandatory to reduce relapse)
  • Nursing: standard precautions only (person-to-person rare); educate on food safety

Dengue Fever

Expat & travel-associated in GCC
  • Vector: Aedes aegypti mosquito (not endemic in GCC desert; imported by travellers/expats)
  • Clinical stages: febrile → critical (plasma leak/haemorrhage) → recovery
  • Warning signs: abdominal pain, vomiting, bleeding, rapid clinical deterioration, fluid accumulation
  • Platelet monitoring: twice daily when <100×10⁹/L; transfuse if <10–20×10⁹/L or active bleeding
  • Nursing: bleeding precautions — soft toothbrush, avoid IM injections, watch for petechiae, gum bleeding, haematuria
  • NO NSAIDs — risk of GI bleeding and platelet dysfunction. Use paracetamol only.
  • Hydration: monitor fluid status carefully during critical phase — too little = shock, too much = pulmonary oedema

Leishmaniasis

GCC desert regions
  • Vector: Phlebotomus sandfly
  • Forms: cutaneous (skin sores — most common), visceral (kala-azar — fatal if untreated)
  • GCC distribution: Saudi Arabia, Yemen border regions, rural/desert areas
  • Treatment: Liposomal amphotericin B (visceral); local therapy for cutaneous
  • Nursing: standard precautions; not person-to-person transmissible
  • Vector control: insect repellents, bed nets, sandfly peak hours dusk to dawn

Hepatitis E

South Asian expat workers
  • Transmission: faecal-oral, contaminated water (waterborne outbreaks), undercooked pork (genotype 3, rare in GCC)
  • At-risk in GCC: South Asian workers in labour camps with poor sanitation
  • Clinical course: self-limiting in most; acute hepatitis 2–6 weeks
  • High mortality in pregnancy — up to 20–25% in 3rd trimester
  • Nursing: contact precautions (enteric); ensure hand hygiene; safe water and food
  • No specific antiviral; supportive management; avoid hepatotoxic drugs

Schistosomiasis

African expat workers
  • Cause: Schistosoma flatworm (haematobium in GCC region)
  • Transmission: contact with contaminated fresh water; cercariae penetrate skin
  • Presentation: haematuria, dysuria (urogenital form); hepatosplenomegaly (intestinal form)
  • GCC context: imported in African migrant workers; irrigated agricultural areas
  • Treatment: Praziquantel single dose
  • Nursing: not person-to-person; standard precautions; screen high-risk migrants
Tuberculosis Nursing

TB Pathogenesis

StageDescriptionInfectious?
Primary TBInitial infection with M. tuberculosis; most form Ghon focus; immune system contains bacteriaRarely
Latent TB (LTBI)Bacteria dormant; no symptoms; TST/IGRA positive; CXR normal or healed lesion; 10% lifetime reactivation riskNo
Active TBBacteria replicating; symptoms: cough >3 weeks, haemoptysis, night sweats, weight loss, feverYes
MDR-TBResistant to isoniazid + rifampicinYes
XDR-TBMDR + resistant to fluoroquinolones + injectable agentsYes

TB Diagnosis

AFB Smear Microscopy

  • Fast (hours), cheap, widely available
  • Sensitivity 60–80% (pulmonary); lower for paucibacillary disease
  • Minimum 3 sputum samples (early morning preferred)
  • Positive = visible acid-fast bacilli (pink rods on Ziehl-Neelsen stain)

Culture (Gold Standard)

  • Most sensitive (can detect <10 bacteria/mL)
  • Takes 6–8 weeks (solid media); 2–3 weeks (liquid — MGIT)
  • Provides drug sensitivity testing (DST)

GeneXpert MTB/RIF

  • Molecular (PCR-based); results in 2 hours
  • Detects M. tuberculosis AND rifampicin resistance simultaneously
  • Sensitivity 88% (smear-positive); 68% (smear-negative)
  • WHO-recommended first-line test in GCC settings

TB Isolation & Infection Control

Airborne Isolation Requirements

  • Negative pressure room — minimum 6–12 ACH (air changes/hour); 12+ preferred
  • Dedicated bathroom; door kept closed at all times
  • Air exhausted outside or through HEPA filter
  • N95 respirator for all staff entering room — fit-tested annually
  • Patient wears surgical mask when outside room
  • Minimum number of staff entering room

Discontinuing Isolation

  • 3 consecutive negative AFB smears (collected 8 hrs apart)
  • Clinical improvement on effective treatment
  • At least 2 weeks of effective therapy

GCC Context — High Migrant TB Burden

  • South Asian workers (India, Pakistan, Bangladesh) — high TB prevalence countries
  • African workers (Ethiopia, Sudan) — high burden countries
  • Pre-employment CXR — mandatory in Saudi, UAE, Qatar for all foreign workers
  • Active TB → deportation in most GCC countries (controversial policy)
  • High turnover of population complicates contact tracing
  • GCC nationals: lower incidence but BCG vaccination maintained

BCG Vaccination

  • Recommended for all neonates in Saudi Arabia and UAE
  • Protects against severe childhood TB (miliary TB, TB meningitis) — 80% efficacy
  • Less protective against adult pulmonary TB
  • Single dose at birth (intradermal left deltoid)
  • Characteristic scar develops over 6–8 weeks

TB Treatment — Standard Regimen

Notation: 2HRZE / 4HR

DrugLetterPhase
Isoniazid (H)HBoth
Rifampicin (R)RBoth
Pyrazinamide (Z)ZIntensive (2 months)
Ethambutol (E)EIntensive (2 months)
2 months intensive (HRZE) → 4 months continuation (HR). Total = 6 months for drug-sensitive TB.

Key Side Effects to Monitor

  • Isoniazid: peripheral neuropathy (give pyridoxine B6), hepatotoxicity
  • Rifampicin: orange urine/tears/sweat, hepatotoxicity, drug interactions (CYP450 inducer — reduces OCP efficacy)
  • Pyrazinamide: hepatotoxicity, hyperuricaemia (gout)
  • Ethambutol: optic neuritis — monthly visual acuity testing

DOT — Directly Observed Therapy

DOT is the standard of care for TB treatment — nurse or community health worker directly observes patient swallowing every dose.
  • Prevents incomplete treatment and MDR-TB development
  • WHO-recommended for all pulmonary TB
  • Can be facility-based (inpatient/OPD) or community-based
  • Video-DOT (VDOT) increasingly used — patient records self taking tablet
  • Document each observed dose

MDR-TB / XDR-TB

  • MDR: resistant to Isoniazid + Rifampicin
  • Minimum 18–20 month regimen
  • Newer drugs: Bedaquiline, Delamanid, Linezolid
  • XDR: additional resistance — even more complex regimens
  • Maintain strict airborne isolation throughout
  • All MDR/XDR cases reportable to MOH

TB — GCC Exam MCQs (DHA/MOH/SCFHS/QCHP Style)

1. A nurse is caring for a patient with suspected pulmonary TB. Which room type is MOST appropriate?
B — Negative pressure isolation room with ≥6 ACH. TB is transmitted by airborne droplet nuclei. Negative pressure prevents escape of air from room. 6–12 ACH is standard; 12+ preferred. Positive pressure rooms are for immunocompromised patients — the opposite indication.
2. A patient with active TB is on standard 2HRZE/4HR treatment. Which side effect requires IMMEDIATE ophthalmology referral?
C — Reduced colour vision and blurred vision. This suggests Ethambutol-induced optic neuritis, which can cause permanent blindness if not identified early. Monthly visual acuity and colour vision testing is mandatory for all patients on Ethambutol. Orange urine = Rifampicin (harmless). Tingling = Isoniazid neuropathy (give pyridoxine).
3. In the GCC, which group has the HIGHEST burden of imported tuberculosis?
C — South Asian and African migrant workers. Countries such as India, Pakistan, Bangladesh, Ethiopia, and Sudan have high TB prevalence. Pre-employment chest X-rays are mandatory in most GCC countries for migrant workers. This population accounts for the majority of TB cases reported in GCC healthcare settings.
4. A nurse obtains a sputum sample for AFB smear from a TB patient. The result is reported as negative. Which statement is CORRECT?
C — Smear-negative TB can still be infectious; clinical suspicion guides continued isolation. AFB smear sensitivity is 60–80%. Smear-negative patients can still have culture-positive TB and remain infectious. Three negative smears collected 8 hours apart are needed to consider discontinuing isolation, combined with clinical improvement and at least 2 weeks of treatment. GeneXpert provides faster confirmation.
5. What is the purpose of Directly Observed Therapy (DOT) in TB management?
B — To ensure patient takes every dose, preventing drug resistance and treatment failure. DOT is the WHO gold standard for TB treatment adherence. A healthcare worker directly observes the patient swallowing each dose. Incomplete treatment is the main driver of MDR-TB development. DOT is especially important in GCC given the mobile migrant population and language/cultural barriers to adherence.
Interactive Tool: Transmission Precautions Selector

Select Suspected / Confirmed Condition

Choose the condition to receive required precaution level and PPE guidance:

Precaution Type:
PPE Required:
Room Type:
Duration:
Hand Hygiene:
Environmental Cleaning:
Key Nursing Notes:
GCC Nurse Infectious Disease Guide | For educational and exam preparation purposes only | Always follow local facility policy and infection control guidance